Was the preterm birth rate in the placebo group too high in the Meis MFMU Network trial of 17-OHPC?
Iams
Jay D
JD
D019326:17-alpha-Hydroxyprogesterone / Q000008:administration & dosage; D002368:Castor Oil / Q000008:administration & dosage; D005260:Female; D006801:Humans; D010121:Oxytocin / Q000502:physiology; D011247:Pregnancy; D011263:Pregnancy Trimester, Third / Q000502:physiology; D047928:Premature Birth / Q000453:epidemiology*; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D018570:Risk Assessment; D012307:Risk Factors; D014590:Uterine Contraction / Q000187:drug effects / Q000502:physiology
D010121:Oxytocin; D019326:17-alpha-Hydroxyprogesterone; D002368:Castor Oil